Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.

Kaur IP, Smitha R.

Drug Dev Ind Pharm. 2002 Apr;28(4):353-69. Review.

PMID:
12056529
2.

Ocular preparations: the formulation approach.

Kaur IP, Kanwar M.

Drug Dev Ind Pharm. 2002 May;28(5):473-93. Review.

PMID:
12098838
3.

Delivery of antiglaucoma drugs: ocular vs systemic absorption.

Urtti A.

J Ocul Pharmacol. 1994 Spring;10(1):349-57. Review.

PMID:
8207339
4.

Enhancement of ocular drug penetration.

Sasaki H, Yamamura K, Mukai T, Nishida K, Nakamura J, Nakashima M, Ichikawa M.

Crit Rev Ther Drug Carrier Syst. 1999;16(1):85-146. Review.

PMID:
10099899
5.

Ophthalmic drug delivery systems--recent advances.

Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R.

Prog Retin Eye Res. 1998 Jan;17(1):33-58. Review.

PMID:
9537794
6.

[Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].

Masteikov√° R, Chalupov√° Z, Savickiene N.

Ceska Slov Farm. 2004 Mar;53(2):73-9. Czech.

PMID:
15095575
7.

Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.

Babizhayev MA.

Drug Dev Ind Pharm. 2008 Oct;34(10):1071-89. doi: 10.1080/03639040801958413 .

PMID:
18777243
8.

Flexible coils with a drug-releasing hydrophilic coating: a new platform for controlled delivery of drugs to the eye?

Pijls RT, Hanssen HH, Nuijts RM, Koole LH.

Biomed Mater Eng. 2004;14(4):383-93.

PMID:
15472387
10.

New directions in the optimization of ocular drug delivery.

Lee VH.

J Ocul Pharmacol. 1990 Summer;6(2):157-64. Review.

PMID:
2203851
11.

Bioadhesive polymers in peptide drug delivery.

Harris D, Robinson JR.

Biomaterials. 1990 Nov;11(9):652-8.

PMID:
2090299
12.

In situ gel systems as 'smart' carriers for sustained ocular drug delivery.

Agrawal AK, Das M, Jain S.

Expert Opin Drug Deliv. 2012 Apr;9(4):383-402. doi: 10.1517/17425247.2012.665367. Review.

PMID:
22432690
13.

Vesicular systems in ocular drug delivery: an overview.

Kaur IP, Garg A, Singla AK, Aggarwal D.

Int J Pharm. 2004 Jan 9;269(1):1-14. Review.

PMID:
14698571
14.

Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.

Bu HZ, Gukasyan HJ, Goulet L, Lou XJ, Xiang C, Koudriakova T.

Curr Drug Metab. 2007 Feb;8(2):91-107. Review.

PMID:
17305490
15.

Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.

Jiao J.

Adv Drug Deliv Rev. 2008 Dec 14;60(15):1663-73. doi: 10.1016/j.addr.2008.09.002. Epub 2008 Sep 20. Review.

PMID:
18845195
16.

Corneal penetration and ocular bioavailability of drugs.

Burstein NL, Anderson JA.

J Ocul Pharmacol. 1985 Fall;1(3):309-26. Review.

PMID:
3916851
17.

Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle.

Gulsen D, Chauhan A.

Int J Pharm. 2005 Mar 23;292(1-2):95-117. Epub 2005 Jan 22.

PMID:
15725557
18.

Recent patents on ocular drug delivery systems.

Conway BR.

Recent Pat Drug Deliv Formul. 2008;2(1):1-8. Review.

PMID:
19075892
19.
20.

Mucoadhesive microspheres for controlled drug delivery.

Chowdary KP, Rao YS.

Biol Pharm Bull. 2004 Nov;27(11):1717-24. Review.

Supplemental Content

Support Center